4/A

OWNERSHIP DOCUMENT

Company: Barinthus Biotherapeutics plc.
Filed: May 7, 2021
Period of Report: May 4, 2021
Accession Number: 0001104659-21-063196

View Document ↗ View on SEC.gov ↗